IL-13可以保护人免受Clostridioides困难结肠炎的侵害
A N Donlan1, J L Leslie2, M E Simpson3
1Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, 98109, USA; Division of Infectious Diseases & International Health, University of Virginia, Charlottesville, VA, 22908, USA.
Anaerobe
|May 3, 2024
概括
介乐-13 (IL-13) 管理保护了小鼠的Clostridioides difficile感染 (CDI),同时阻止IL-13恶化疾病. 这突出了IL-13的特点.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 胃肠病学 胃肠病学
背景情况:
- 艰难菌感染 (CDI) 是一个主要的医院获得的感染.
- 抗生素的使用破坏了肠道微生物群,减少了像IL-33和IL-25这样的保护性细胞因子.
- 通过ILC2s传递IL-33信号产生IL-13,但IL-13在CDI中的作用尚不清楚.
研究的目的:
- 在CDI的小鼠模型中研究IL-13的作用.
- 为了确定IL-13是否影响CDI期间的疾病严重程度和免疫细胞反应.
主要方法:
- 使用了经过验证的CDI小鼠模型.
- 服用复合IL-13或阻断IL-13的抗体.
- 使用减肥和临床分数分析疾病严重程度.
- 使用光激活细胞分类 (FACS) 鉴定了髓状细胞群的特征.
主要成果:
- 给予IL-13给予了对CDI的保护.
- 阻断IL-13加剧了CDI的严重程度.
- IL-13中和改变了单细胞/巨细胞的数量,增加了髓状细胞的积累.
- 中和受体IL-13诱受体 (IL-13Rα2) 保护免受CDI.
结论:
- IL-13在CDI中起着保护作用,减轻了疾病的严重程度.
- 单细胞/巨细胞区的失调与对CDI的反应不佳有关.
- 这些发现增强了对CDI2型免疫的理解,并表明了治疗潜力.
相关概念视频
Renewal of Intestinal Stem Cells
2.6K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.6K
Drugs for Treatment of Ulcerative Colitis in IBD
138
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
138
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
160
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
160


